Bictegravir Use During Pregnancy: A Multi-Center Retrospective Analysis Evaluating HIV Viral Suppression and Perinatal Outcomes.

Authors :: Holt LM
Short WR
Momplaisir F
Hyun E
McKinney J
Lugo Morales A
Duque A
Druyan B
Ndubizu C
Duthely L
Joseph N
Sheth A
Badell ML
Source :: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Apr 26. Date of Electronic Publication: 2024 Apr 26.
Publication Year :: 2024
Publisher :: Ahead of Print
Abstract: This study describes the largest cohort to date (n=147) of pregnant patients living with HIV on bictegravir (BIC). BIC in pregnancy was associated with high levels of viral suppression and similar perinatal outcomes to published literature. These findings support consideration for use of BIC in management of HIV during pregnancy.<br /> (© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)

Language :: English
ISSN :: 1537-6591
Database :: MEDLINE
Journal :: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publication Type :: Academic Journal
Accession number :: 38666408
Full Text :: https://doi.org/10.1093/cid/ciae218

Full Text Access

Tools